Background: ALS patients with hexanucleotide expansion in C9orf72 are characterized by a specific clinical phenotype, including more aggressive disease course and cognitive decline. Computerized multiparametric MRI with gray matter volumetry and diffusion tensor imaging (DTI) to analyze white matter structural connectivity is a potential in vivo biomarker. Objective: The objective of this study was to develop a multiparametric MRI signature in a large cohort of ALS patients with C9orf72 mutations. The aim was to investigate how morphological features of C9orf72-associated ALS differ in structural MRI and DTI compared to healthy controls and ALS patients without C9orf72 mutations. Methods: Atlas-based volumetry (ABV) and whole brain-based DT...
The unmistakeable neurodegenerative disease amyotrophic lateral sclerosis (ALS) is a common clinical...
Objective To discern presymptomatic changes in brain structure or function using advanced MRI in car...
International audienceThe development of new possible treatments for C9orf72-related ALS and the pos...
BACKGROUND: In patients with a C9orf72 repeat expansion (C9+), a neuroimaging phenotype with widespr...
OBJECTIVE: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
AbstractExpansion mutations in the C9orf72 gene may cause amyotrophic lateral sclerosis (ALS), front...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Expansion mutations in the C9orf72 gene may cause amyotrophic lateral sclerosis (ALS), frontotempora...
Now that genetic testing can identify persons at risk for developing amyotrophic lateral sclerosis (...
Objective: To investigate possible effects of the C9orf72 repeat expansion before disease onset, we ...
Background: The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral...
International audienceImportance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9o...
Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was designed for testing patients with amyotro...
Background: The criteria for assessing upper motor neuron pathology in pure lower motor neuron disea...
Background: The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral...
The unmistakeable neurodegenerative disease amyotrophic lateral sclerosis (ALS) is a common clinical...
Objective To discern presymptomatic changes in brain structure or function using advanced MRI in car...
International audienceThe development of new possible treatments for C9orf72-related ALS and the pos...
BACKGROUND: In patients with a C9orf72 repeat expansion (C9+), a neuroimaging phenotype with widespr...
OBJECTIVE: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
AbstractExpansion mutations in the C9orf72 gene may cause amyotrophic lateral sclerosis (ALS), front...
Objective: To understand the progressive nature of amyotrophic lateral sclerosis (ALS) by investigat...
Expansion mutations in the C9orf72 gene may cause amyotrophic lateral sclerosis (ALS), frontotempora...
Now that genetic testing can identify persons at risk for developing amyotrophic lateral sclerosis (...
Objective: To investigate possible effects of the C9orf72 repeat expansion before disease onset, we ...
Background: The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral...
International audienceImportance Presymptomatic carriers of chromosome 9 open reading frame 72 (C9o...
Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was designed for testing patients with amyotro...
Background: The criteria for assessing upper motor neuron pathology in pure lower motor neuron disea...
Background: The neuropathology of patients with frontotemporal dementia (FTD) or amyotrophic lateral...
The unmistakeable neurodegenerative disease amyotrophic lateral sclerosis (ALS) is a common clinical...
Objective To discern presymptomatic changes in brain structure or function using advanced MRI in car...
International audienceThe development of new possible treatments for C9orf72-related ALS and the pos...